EUVIMEDEUVIMED entdecken
Crossref

Current status of low‐density lipoprotein apheresis treatment for patients with peripheral artery disease and chronic kidney disease in Japanese clinical database

Yu Watanabe, Akihito Tanaka, Kazuhiro Furuhashi, Shoichi Maruyama

Therapeutic Apheresis and Dialysis · 2023

DOI: 10.1111/1744-9987.14046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2023. Verfasst von Yu Watanabe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Hauptthemen laut MEDLINE: Blood Component Removal, Peripheral Arterial Disease, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: Aichi Jinzou Zaidan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients with peripheral arterial disease (PAD) have a poorer prognosis than those without PAD. PAD complications worsen the prognosis of patients with chronic kidney disease (CKD), especially those on maintenance dialysis. Although low‐density lipoprotein apheresis (LDL‐A) is expected to be effective in treating severe PAD, there are no large‐scale reports on the prognosis of patients undergoing LDL‐A.

Methods

We obtained a clinical database from April 2008 to August 2021 and selected 924 238 patients with CKD. We selected patients with disease codes of lower limb arteriosclerosis obliterans, arteriosclerosis obliterans, and critical limb ischemia or foot ulcer. Patients who were prescribed antithrombotic medications were included. Patients who used steroids were excluded. Among these patients, those undergoing blood purification considered LDL‐A were selected, and their current status was investigated.

Results

We included 147 patients (113 males and 34 females). The mean patient age was 70 ± 10 years. Diabetes mellitus was present in 86%, ischemic heart disease in 34%, and stroke in 48%. Maintenance dialysis patients accounted for 86% of the patients. Statins were administered to 40% of the patients, and bypass surgery was performed in 2.7%. The median observation period was 812 days, and the mortality rate was 41%.

Conclusion

LDL‐A was performed in a small population of patients with CKD with the most severe form of PAD. The prognosis for these patients is extremely poor. Therefore, strategies to improve prognosis are important.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Component RemovalPeripheral Arterial DiseaseRenal Insufficiency, ChronicMaleFemaleHumansMiddle AgedAgedAged, 80 and overEast Asian PeopleLipoproteins, LDL

Stichwörter der Autor:innen

arteriosclerosis obliteranschronic kidney diseaselow-density lipoprotein apheresismortalityperipheral artery disease

Substanzen

Lipoproteins, LDL

Autor:innen und Institutionen

  • Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Department of Nephrology, Nagoya University Hospital, Nagoya, Aichi, Japan.

Förderung

  • Aichi Jinzou Zaidan

Zitieren

APA

Watanabe, Y., Tanaka, A., Furuhashi, K., & Maruyama, S. (2023). Current status of low‐density lipoprotein apheresis treatment for patients with peripheral artery disease and chronic kidney disease in Japanese clinical database. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14046

Vancouver

Watanabe Y, Tanaka A, Furuhashi K, Maruyama S. Current status of low‐density lipoprotein apheresis treatment for patients with peripheral artery disease and chronic kidney disease in Japanese clinical database. Therapeutic Apheresis and Dialysis. 2023. doi:10.1111/1744-9987.14046

BibTeX
@article{Watanabe2023,
  author = {Watanabe, Yu and Tanaka, Akihito and Furuhashi, Kazuhiro and Maruyama, Shoichi},
  title = {Current status of low‐density lipoprotein apheresis treatment for patients with peripheral artery disease and chronic kidney disease in Japanese clinical database},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2023},
  doi = {10.1111/1744-9987.14046}
}
Kostenlos starten →